Various estrane derivatives 1 reacted with cerium ammonium nitrate (CAN) selectively and efficiently to provide 9 alpha,11 beta-defunctionalized derivatives 2, which were subsequently deoxygenated at C-9 with triethylsilane/boron trifluoride etherate to the desired target 11 beta-nitratoestranes 3a, 3b, and 5. When examined for estrogenic and postcoital antifertility activity, 11 beta-nitrates 2c, 2d, and 3b most notably displayed more potent oral activity than did ethynylestradiol.
7.alpha.-Methyl- and 11.beta.-ethoxy-substitution of iodine-125-labeled [125I]16.alpha.-iodoestradiol: effect on estrogen receptor-mediated target tissue uptake
摘要:
The 7alpha-methyl and 11beta-ethoxy derivatives of 16alpha-[I-125]iodoestradiol were prepared via halogen exchange with I-125 of the corresponding 16beta-bromoestradiol precursors. The 16alpha-bromo derivatives were obtained via halogenation of the analogous 17-enol acetate, epimerization to the 16beta-isomer, and hydride reduction. Stereochemical assignments were based on high resolution H-1 NMR. To evaluate the effect of the nature and stereochemistry of the 16-halo substituent on the relative binding affinity for the estrogen receptor, the analogous 16-chloro derivatives were also prepared. The highest binding affinities were observed with the 7alpha-methyl-16alpha-haloestradiols, particularly the bromo and chloro derivatives while the 16alpha-iodo derivatives gave somewhat lower values. Both the 11beta-ethoxy and 7alpha-methyl-16alpha-[I-125]iodoestradiols localize in the uteri of immature female rats via a receptor-mediated process. Rapid blood clearance of the I-125-labeled 7alpha-methyl derivative results in lower I-125 uptake by the uterus as well as nontarget organs as compared to the 11beta-substituted estradiol analogs. However, uterus to blood and nontarget ratios are more favorable for the 7alpha-methyl-16alpha-[I-125]iodoestradiol as compared to the analogous 11beta-ethoxy derivatives suggesting that this compound substituted with I-125 may be useful for the in vivo imaging of estrogen receptor-rich breast tumors by single photon emission computerized tomography.
[EN] ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE<br/>[FR] DERIVES DE 1,3,5(10)-ESTRATRIENE ACTIFS PAR VOIE ORALE
申请人:THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
公开号:WO1995007925A1
公开(公告)日:1995-03-23
(EN) 17$g(b)-nitrate and 11$g(b),17$g(b)-dinitrate esters of estradiol which exibit elevated estrogenic and postcoital contraceptive activities are disclosed. A process for their manufacture and their use in pharmaceuticals is also disclosed.(FR) L'invention concerne décrit des dinitrate-17$g(b)-nitrate et 11$g(b)-,17$g(b)-ester d'estradiol, qui présentent une activité oestrogénique et contraceptive postcoïtale élevée. Un procédé pour leur fabrication et leur utilisation dans des produits pharmaceutiques est également décrit.